Anixa Biosciences, Inc.
ANIX
$3.09
-$0.17-5.22%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.70M | -2.26M | -2.79M | -3.18M | -2.88M |
| Total Depreciation and Amortization | 9.00K | 9.00K | 9.00K | 9.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 834.00K | 820.00K | 1.14M | 774.00K | 974.00K |
| Change in Net Operating Assets | 597.00K | -82.00K | 140.00K | -503.00K | 973.00K |
| Cash from Operations | -1.26M | -1.51M | -1.50M | -2.90M | -927.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 654.00K | -833.00K | 2.34M | 2.70M | 867.00K |
| Cash from Investing | 654.00K | -833.00K | 2.34M | 2.70M | 867.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 332.00K | 2.05M | 4.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -3.00K | -- | -33.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.00K | -123.00K | 17.00K | -17.00K | 139.00K |
| Cash from Financing | 350.00K | 1.93M | 18.00K | -17.00K | 106.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -251.00K | -415.00K | 857.00K | -218.00K | 46.00K |